Johnson & Johnson Announces Caplyta (Lumateperone) Shows Significant And Rapid Improvement In Bipolar Mania In Second Pivotal Phase 3 Study
Caplyta Significantly Improves Manic Symptoms And Illness Severity At Week 3
Related stories
Adobe Brings Google AI Models To Firefly, Photoshop, Acrobat
L impact | NEWS | Nov 10, 2026, 02:07 PM UTC
Adobe & Google Deepen AI Partnership
L impact | NEWS | Nov 10, 2026, 02:05 PM UTC
Adobe & Google deepen AI partnership. $ADBE $GOOGL
L impact | NEWS | Nov 10, 2026, 02:05 PM UTC
Adobe: Expands Creative Agent Across Firefly AI Creative Studio
L impact | NEWS | Nov 10, 2026, 02:01 PM UTC
US Redbook YoY Actual 10.1% (Forecast -, Previous 10.4%)
L impact | NEWS | Nov 10, 2026, 01:55 PM UTC
US Senate backs permitting bill aimed at accelerating energy construction
Democrats’ decisive victory in last week’s midterms have added impetus to permitting reform. The US Senate advanced major permitting reforms aimed at speeding up the construction o
L impact | NEWS | Nov 10, 2026, 01:50 PM UTC